We have created a first idea of the SUNSHINE SIA e-infrastructure, moved forward with our case studies and performed a first stakeholder workshop.

The research officer will be based in the Institute of Life Science that hosts a wide range of research activityin state-of-the-art facilities on the Singleton Campus of Swansea University. They will support researchactivity in the In Vitro Toxicology Research Group (IVTG), carry out primary research involving patients (andin vitro cell models) and help supervise PhD, Masters and BSc students. The post holder will carry out patientfocussed cancer research, collecting tissue samples from patients at Singleton hospital and processing themin the laboratory for mutational endpoints. The post holder will also carry out mutation research in vitro(using cell-based 2D and 3D systems). The post holder will oversee the ethical and research governanceaspects associated with the patient-based research.

For more information click HERE.

A joint workshop has been organized, aiming to transfer GRACIOUS results to the newly started NMBP-16 projects (DIAGONAL, HARMLESS and SUNSHINE). For further details about the workshop, please continue reading our article.

In the past couple of months, we have worked hard to create a visual identity for our project that reflects who we are and how we do science. And now we are happy to share it with you!

Read the latest project news in our press release for June 2021.

The new EU-funded SUNSHINE project develops and validates Safe and Sustainable-by-Design strategies for products enabled by multi-component nanomaterials and facilitates their implementation at the industrial scale.

Find out more about the project in our press release.